Indian Journal of Biotechnology
Vol 6, July 2007, pp 329-335
Expression of 3AB protein of foot and mouth disease virus in Pichia pastoris
M Latha Priyadharshini1, V Balamurugan, K Prabhudas, V V S Suryanarayana and G R Reddy*
Molecular Virology Laboratory, Indian Veterinary Research Institute, Hebbal, Bangalore 560 024, India 1Department of Microbiology, Madras Veterinary College, Chennai 600 007, India.
Received 19 August 2005; revised 5 July 2006; accepted 15 Ocotber 2006
3AB non structural protein (nsp) was used to diagnose the vaccinated animals from those infected with foot and mouth
disease virus (FMDV). In order to express the gene encoding 3AB protein of FMDV type A22 in Pichia pestoris, the gene
was amplified and cloned into the yeast transfer vector (pPIC-9K) at EcoRI site. The cloned gene was further characterized
by colony PCR, restriction enzyme digestion and sequence analysis. The recombinant plasmid was transferred into GS115
strain of P. pastoris cells by electroporation. The His+ Pichia transformants were analyzed for the presence of the insert in
the yeast genome by PCR. PCR positive clones were grown and expression was induced with 0.5% methanol. The expressed
gene products were then characterized by SDS-PAGE and Western blot analysis. This is the first report on the production of
FMDV non structural proteins in yeast. The expressed protein will be of diagnostic importance.
Keywords: 3AB protein, expression, FMDV, Pichia pastoris
IPC Code: Int. Cl.8 C12N 15/09, 15/11
Introduction
Foot and mouth disease virus (FMDV) causes a
devastating disease in cattle, pigs and sheep. The
disease can spread rapidly among susceptible
populations and has a great impact on the economy of
the affected countries. Where the disease is sporadic,
control of the disease is by slaughtering the affected
and in-contact animals, whereas in enzootic areas, the
control is by regular vaccination and restricted animal
movement. Animals recovered from the FMD can
become persistent carriers of the virus, in which case
the subjects carry the virus for several years1. The
carrier animals harboring the sub clinical infection
may be a source for new outbreaks. It is possible that
these carrier animals intermittently shed variants of
the virus, which differ antigenically from the original
strain2. Vaccination, thus, may be less effective in
these animals due to the variant viruses. Detection of
animals exposed to the disease in the livestock
population is very essential for effective FMD control
programmes. In fact, detection of replicating FMDV
in the vaccinated animals not manifesting clinical
signs is as relevant as the diagnosis of the acute
infection itself, since it acts as an indicator for vaccine
performance.
In endemic countries, like India, where regular
vaccination is carried out in the susceptible
population, majority of the susceptible animals are
sero-positive for structural proteins and it is not
possible to determine whether the animal is exposed
to the disease using whole virus as antigen. Since
non-structural proteins (nsps) are not present in
vaccine preparations3,4
, detection of antibodies to
these proteins is of diagnostic value whether the
animal/herd is exposed to the disease or not5.
Therefore, the present requirement is to develop a
serological test capable of differentiating vaccinated
from the FMDV infected animals. Such a test would
not only be useful to detect viral persistence but also
for serological surveys to be carried out for FMD
eradication. The test so developed should be highly
specific and sensitive, simple, innocuous and
inexpensive.
Nsps 2C, 3AB, 3ABC expressed in different
expression systems have been used in the ELISA and
other serological tests to detect the antibodies in
infected animals 6. The recent reports have suggested
that antibodies to 2C/3ABC/3AB could be the best
serological indicator of infection with FMDV.
However, these nsps produced in Escherichia coli
showed poor reactivity with sera of infected animals
probably due to poor solubility of the protein
expressed in bacteria7. Though the proteins produced
in insect cells are soluble, maintenance of the insect
______________________
*Author for correspondence:
Tel: 91-80-23418078; Fax: 91-80-23412509
E-mail: [email protected]
INDIAN J BIOTECHNOL, JULY 2007
330
cells is laborious and costly. Yeast expression system,
on the other hand, has several advantages over
bacterial and insect cell systems, i.e. good over
expression level, secretion of protein into the medium,
ease of maintenance of the cells and scaling up
production8. The present study reports the expression
of 3AB in the yeast, Pichia pastoris.
Materials and Methods Virus
FMDV serotype A (Ind 17/77) vaccine strain was
grown in BHK-21 cl 13 monolayers. The seed virus
was obtained from the FMD vaccine production
laboratory of the Institute.
Sera Samples and Conjugate
Rabbit hyper immune serum against recombinant
3AB of FMDV expressed in E. coli and rabbit anti-
bovine IgG-HRPO conjugate, available in the
laboratory, were used. Goat anti-rabbit IgG-HRPO
conjugate was procured from Bangalore Genei
Bangalore, India.
Host Strain and Plasmid Vector
P. pastoris host strain, used in the study, was the
histidine requiring auxotroph GS115 (His4) pPIC-9K,
whereas yeast transfer vector contained AOX1
promoter and transcription termination sequences
along with MCS for insertion of the foreign genes of
interest and wild type copy of the histidinol
dehydrogenase (His4) gene for selection of P.
pastoris transformants. Both GS115 (His4) host strain
as well as plasmid pPIC-9K were procured from
Invitrogen, USA.
Amplification and Cloning of 3AB
Total RNA was extracted from infected BHK-21
cell culture supernatant using Trizol reagent
(Invitrogen, USA). The cDNA copy was synthesized
using the purified RNA as a template and 3dt
(5′ dTTTTTTAAAGAAAAGGAAG-OH3′) as a
primer with M-MLV (Molony Murine Leukemia
Virus) reverse transcriptase as per standard procedure.
The 3AB sequence was amplified from the cDNA
using 3Aln (5′d-GGT GAT TGA CCG GGT TGA G-
OH 3′) and VPgR (5′d- GAC TAT CGA ATT CTT
AGC TTT CTC -OH 3′) as upstream and downstream
primers, respectively. All the primers were designed
based on the published FMDV A12 sequence data9. A
50 µL reaction mix containing 1.5 mM MgCl2, 100
µM each of dNTPs, 25 mM Tris-HCl, 50 mM KCl, 20
pmol of each primer and one unit of Taq DNA
polymerase was amplified in the DNA Thermal
Cycler 9600 (Perkin-Elmer Cetus, USA) with initial
denaturation at 94ºC for 3 min, followed by 35 cycles
of 94ºC for 1 min, 60ºC for 1 min and 72º C for 1 min
with a final extension at 72ºC for 10 min.
The amplified PCR product corresponding to 3AB
(672 bp) gene was purified using wizard PCR
prep DNA purification system (Promega, USA),
digested with EcoRI and the digested product
(589 bp) was cloned into the pPIC-9K at
EcoRI site. The recombinant colonies grown on
kanamycin plates were initially screened
by colony PCR, using vector specific 5′AOXI
(5′dGACTGGTTCCAATTGACAAGC-OH3′) and
insert specific VPgR (3’end of the insert) primer to
check orientation of the insert, followed by insert
release from the recombinant plasmid DNA. The
recombinant plasmid with correct orientation of the
insert (pPICA22-3AB) was used for further study.
Sequencing of 3AB Gene
The 3AB insert in plasmid (pPIC-9K) was
sequenced with 3'AOX1 (5'dGCAAATGGCATT-
CTGA-OH3') and 5’AOX1 primers using the ABI
377 automated DNA sequencer (ABI Inc., USA) to
confirm the frame and specificity of the cloned
fragment. The sequence reaction was carried out
using 1 µg of plasmid DNA and 2 pmol of the primer.
Sequence data obtained was analyzed with the help of
Omiga 1.13 DNA analysis software. Both nucleotide
and derived amino acid sequences were compared
with A12 sequence.
Expression of Cloned 3AB in P. pastoris
The pPICA22-3AB plasmid was linearized with
SalI and transferred into GS115 strain of P. pastoris
by electroporation for 10 msec with field strength of
7500 V/cm using Gene Pulsar II (Bio-Rad, USA).
Transformants harbouring the plasmid-borne His4
marker were selected on minimal plates lacking
histidine. Yeast chromosomal DNA was extracted
from the transformants (Mut+) by spheroplasting with
zymolyase, followed by phenol:chloroform
extraction.
Presence of the insert in the yeast genome was
confirmed by PCR amplification using 5’ AOX1 and
3’AOX1, vector specific primers. Induction of the
protein expression was carried out by standard
procedures8. Single colony of the His
+Mut
+ positive
clone and the vector transformant of Pichia was
inoculated in 25 mL buffered glycerol-complex
PRIYADHARSHINI et al.: EXPRESSION OF FMDV 3AB PROTEIN GENE IN PICHIA PASTORIS
331
medium (BMGY), kept in two 250 mL flasks, and
incubated at 30°C in a shaking incubator (250-300
rpm) to reach an A600 of 6. The cells were harvested
and suspended in buffered methanol-complex medium
(BMMY) to an A600 of 1.0 (about 100-200 mL
medium) and incubated at 30°C, and methanol was
added to a final concentration of 0.5% at every 24 h
interval up to 96 h. After 96 h incubation, entire
culture supernatant was harvested and the secreted
proteins were precipitated with 50% ammonium
sulfate, and dialyzed against phosphate buffered
saline (PBS, pH 7.4)). The protein content was
estimated by Bradford method11
with bovine serum
albumin (BSA) as the standard. Partially purified
proteins, from the recombinant Pichia clone along
with control pPIC-9K were separated on 15%
polyacrylamide gels under denaturing conditions
(SDS-PAGE) as per the method of Laemmli12
.
A similar duplicate gel was blotted onto a PVDF
membrane for immuno detection. The recombinant
protein was detected by treating with anti-3AB rabbit
serum (at 1:800 dilution), followed by an anti-rabbit
antibody HRPO conjugate (1:1000) and
orthodianisidine dihydrochloride (ODD) as
substrate11
.
Results Cloning of 3AB in Yeast Transfer Vector
The 3AB-coding sequence was amplified by RT-
PCR using RNA extracted from the virus, which
resulted in the amplification of specific PCR product
of 670 bp (Fig. 1, lane 2). The amplified product was
purified, digested with EcoRI and ligated with EcoRI
digested pPIC-9K vector. Presence of the insert
(containing 3B and truncated 3A) in the recombinant
plasmids was confirmed by EcoRI digestion. Release
of 0.6 kb fragment confirmed the presence of the
insert. Orientation of the insert in the plasmid was
confirmed by PCR with 5’AOX1 (vector specific) and
VPgR (virus specific) primers. Amplification of 1 kb
product (Fig. 2, lane 1) showed that the insert is in 5’-
3’ orientation whereas amplification of 0.4 kb product
indicated the 3’-5’ orientation (Fig. 2, lanes 2 & 3). Sequencing of 3AB Clone
Nucleotide and the amino acid sequence of cloned
3AB gene of serotype A (Indian vaccine strain) is
shown in Fig. 3. The cloned 3AB gene is of 672
nucleotides and codes for 224 amino acids. After
digestion with EcoRI, the PCR fragment (589 bp) was
cloned into pPIC-9K, a yeast transfer vector, and
Fig. 1—Agarose gel electrophoresis of amplified PCR products:
lane 1, Negative control (without cDNA); lane 2, PCR product
(3AB) amplified from cDNA; & lane M, Standard DNA
molecular weight marker (100bp ladder, Invitrogen, USA).
Fig. 2—Agarose gel electrophoresis of PCR products amplified
from recombinant plasmids with 3AB inserts: lane M, Standard
DNA molecular weight marker (100bp ladder Invitrogen, USA);
lane 1, Amplified PCR products from the plasmid with 3AB insert
in correct orientation; lanes 2 & 3, Amplified PCR products from
the plasmids with 3AB insert in reverse orientation; & lane 4,
pPIC-9K vector control.
INDIAN J BIOTECHNOL, JULY 2007
332
frame and orientation of the insert was confirmed by
sequencing. The insert was in frame with vector
coded ATG codon. The sequence of the cloned insert
and the deduced amino acid sequence translated in +3
frame as shown in Fig. 3. To examine the relation
with reported sequence of the serotype A (A12 strain),
nucleotide and the amino acid sequences of both the
strains were aligned (Fig. 4), which indicated a
homology of 90% in the nucleotide sequence and
96% in amino acid sequence, confirming that the
sequence cloned was of 3AB gene. Variation in the
amino acid sequence was more pronounced in 3A
compared to the 3B protein.
Transformation of pPICA22-3AB into Pichia pastoris
In order to express the 3AB gene, recombinant
plasmid (pPICA22-3AB) was linearized with SalI and
was transferred into GS115 strain of Pichia by
electroporation with linearized pPIC-9K vector as
control. The recombinant Pichia clones were screened
for confirming the presence of 3AB insert in the yeast
genome by PCR using vector specific primers.
Histidine positive clones with at least one integrated
copy of the expression cassette can be easily
distinguished from un-transformant colonies by
comparing the size of PCR products amplified in PCR
colony using the 5’AOX1 and 3’AOX1 primers. The
Fig. 3—Nucleotide sequence and deduced amino acid sequence of 3AB of FMDV serotype A ( Indian strain).
PRIYADHARSHINI et al.: EXPRESSION OF FMDV 3AB PROTEIN GENE IN PICHIA PASTORIS
333
chromosomal DNAs from the individual clones were
prepared and subjected to PCR. Amplification of
specific 1.1 kbp product (corresponding to 612 bp
insert and rest is from the vector) could be seen in the
gel (Fig. 5, lanes 1 & 2). Of the five colonies screened
by PCR for integration, two were found to carry the
vector with 3AB insert, which were used for protein
expression.
Expression of 3AB in Pichia pastoris
The PCR positive Pichia clones were grown
separately and the expression was induced with 0.5%
methanol. Since the inserted gene is present
downstream to the secretary signal sequences, the
expressed gene product was expected to be secreted
out in the medium. Proteins expressed by recombinant
clones carrying integrated DNA with and without
insert in the culture supernatants were analyzed by
SDS-PAGE, followed by Western blot analysis. A
protein band of 26 kDa was seen in the gel (Fig. 6,
lane 3) corresponding to 3AB protein. Protein bands
separated in the gel were transferred on to PVDF
membrane and detected with antiserum specific to 3AB
(Fig. 7). An intensive color reaction was observed with
the protein band size corresponding to 26 kDa from
recombinant clone (Fig. 7, lane 1) which confirms the
expression of 3AB protein by P. pastoris.
Discussion
In India, diagnosis based on the detection of
antibodies to viral nsps is important to assess the
prevalence of endemic disease. The antibodies against
Fig. 4—Alignment of amino acid sequences of 3AB of FMDV Sero type A strains.
INDIAN J BIOTECHNOL, JULY 2007
334
virus capsid show the sero-conversion in the
vaccinated animals, while the presence of antibodies
against nsps shows the disease prevalence situation
either due to previous out brakes or presence of the
residual live virus in case of vaccinated animals.
Diagnosis of infection at sub-clinical level is very
much relevant both in the control and eradication of
FMD in endemic areas and as a supportive measure to
the ‘stamping out’ policy in FMD-free areas. The poly
protein 3AB and 3ABC have been proposed as the
most antigenic of the FMDV nsps and it has been
argued that antibody specific for these proteins could
be the most useful marker of viral replication14,15
.
Hence, presence of antibodies against these nsps
certainly indicates viral multiplication in the animal.
Recently, the yeast has emerged as a powerful
heterologous expression system for the production of
high levels of functionally active recombinant
proteins8. To expedite such approaches that circumvent
several problems encountered in expressing the 3AB,
we expressed 3AB protein in yeast P. pastoris system.
The cloning of the 3AB sequence downstream to the
highly inducible AOX1 promoter and signal peptide
permitted high-level expression and secretion of the
recombinant protein. The translated product is in the
form of a fusion protein, which gets secreted out after
cleavage of the signal sequences. Using SalI linearized
pPICA22-3AB plasmid in Pichia, homologous
recombination between the transforming DNA and
region of homology within the yeast genome is
generally expected to occur within the His4 locus,
which leads to the generation of Mut+ recombinant of
GS115 cells2,10
. Electroporation method of transform-
ation in Pichia yielded 2×103 His+ transformants/µg of
DNA, which is less than reported in Saccharomyces
(103-10
4/µg of DNA)
17,18.
Fig. 5—Agarose gel electrophoresis of PCR amplified 3AB
inserts from Pichia clones: lane M, Standard molecular weight
marker (100bp ladder, Invitrogen, USA; lane 1 & 2, Amplified
PCR products from the chromosomal DNA of clones with 3AB
insert; lane 3, Amplified PCR products from the chromosomal
DNA of parent strain (GS115) showing the AOX 1 gene intact;
lane 4, Amplified PCR products from the chromosomal DNA of
clones with pPIC-9K; lane 5, Amplified PCR products from pPIC-
9K recombinant clone (positive control); lane 6, Amplified PCR
products from pPIC-9K vector; & lane M, Standard molecular
weight marker (100bp ladder, Bangalore Genei, Bangalore).
Fig. 6—SDS-PAGE Analysis of Expressed FMDV Protein: lane
1, Proteins from culture supernatant of yeast cells (GS115); lane
2, Protein from induced culture supernatant of yeast cells without
insert; lane 3, Protein from induced culture supernatant of yeast
cells with 3AB insert; & lane M, Standard protein molecular
weight marker (PMW-L, Bangalore, Genei, Bangalore).
Fig. 7—Western blot analysis of expressed FMDV protein; lane,
1: Culture supernatant of induced yeast cell culture carrying 3AB
insert; & lane 2, Culture supernatant of yeast cell carrying no
insert.
PRIYADHARSHINI et al.: EXPRESSION OF FMDV 3AB PROTEIN GENE IN PICHIA PASTORIS
335
The quantity of protein expressed by the
recombinant yeast clone was 200 mg/L culture
supernatant, which is in the range of 6.3 mg to 12g/L
culture depending on the nature of the protein as
reported by various groups18,19
. The calculated size of
the 3AB comes to 23 kDa, which is in agreement with
the protein size observed in SDS-PAGE. This indicates
that the product is from the cloned gene.
In conclusion, the results show the expression of
3AB gene of FMDV serotype A vaccine strain in P.
pastoris, which will be useful for development of
diagnostic test to differentiate the vaccinated from the
infected animals.
Acknowledgment
We wish to thank the Director, IVRI, Izatnagar and
Joint Director, IVRI, Bangalore for providing all the
facilities to carry out this work. We are indebted to
late Dr S M Lal, ex-Joint Director, IVRI, Bangalore
Campus, for his support and encouragement.
References 1 Hedger R S, the isolation and characterization of foot-and-
mouth disease virus from clinically normal herds of cattle in
Botswana, J Hyg, 66 (1968) 27-36.
2 Bergmann I E, de Mello P A, Neitzert E, Beck E & Gomes I,
Diagnosis of persistent aphthoviral infection and its
differentiation from vaccination response in cattle by use of
enzyme-linked immunoelectrotransfer blot analysis with
bioengineered non structural viral antigens, Am J Vet Res, 54
(1993) 825-831.
3 Cowan K M & Graves J H, A third antigenic component
associated with foot and mouth disease infection, Virology, 30
(1966) 528-540.
4 Graves J H, McVicar V W & Yedloutsching R J, Review of
the VIA reaction in diagnosis of foot and mouth disease, in
Proc 81st Annu Meet US Anim Health Assoc (US Animal
Health Association) 1978, 256-263.
5 Rodriguez A, Dopazo J, Saiz, J C & Sobrino F,
Immunogenecity of non-structural proteins of foot-and-mouth
disease virus: Differences between infected and vaccinated
swine, Arch Virol, 136 (1994) 123-131.
6 Mackey D K J, Differentiating infection from the vaccination
in foot and mouth disease, Vet Q, 20/52 (1998) 2-5.
7 Lubroth J, Grubman M J, Burrage T G, Newman J F E &
Brown F, Absence of protein 2C from clarified FMDV
vaccines provides the basis for distinguishing convalescent
from vaccinated animals, Vaccine 14 (1996) 419-427.
8 Cereghino J L & Cregg J M, Heterologous protein expression
in methylotrophic yeast Pichia pastoris, FEMS Microbiol Rev,
24 (2000) 45-66.
9 Robertson B H, Grubman M J, Weddel, G N, Moore D M,
Welsh J D et al, Nucleotide and amino acid sequence coding
for polypeptides of foot and mouth disease virus type A12, J
Virol, 54 (1985) 651-660.
10 Cregg J M & Higgins D R, Production of foreign protein in
yeast Pichia pastoris, Can J Bot (Suppl), 73 (1995) 5981-5987.
11 Bradford M M, A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding, Anal Biochem, 72 (1976)
248-254.
12 Laemmli U K, Cleavage of structural protein during the
analysis of head of bacteriophage T4, Nature (Lond), 227
(1970) 680-685.
13 Suryanarayana V V S, Rao B U & Padayatty J D, Expression
of E. coli the cloned cDNA for the major antigen of foot-and-
mouth disease virus Asia-1 63/72 J, Genetics, 65 (1986) 19-30.
14 Diego M de, Bronchi E, Mackay D & Simone F de, The non-
structural poly protein 3ABC of foot and mouth disease virus
as a diagnostic antigen in ELISA to differentiate infected from
vaccinated cattle, Arch Virol, 142 (1997) 2021-2033.
15 Silberstein E, Kaplan G, Tobago O, Duffy S & Palma E, Foot
and mouth disease virus infected, but not vaccinated cattle
develop antibodies against recombinant 3AB1 non-structural
proteins, Arch Virol, 142 (1997), 795-805.
16 Cregg J M, Baringer K J & Hessler A Y, Pichia pastoris as a
host system for transformations, Mol Cell Biol, 5 (1985) 3376 -
3385.
17 Hinnen A, Hicks J B & Fink G R, Transformation of yeast,
Proc Natl Acad Sci USA, 75 (1978) 1929-1933.
18 Romanos M A, Clare J J, Beesley K M, Rayment F B,
Ballantine S T et al, Recombinant Bordetella pertussis
pertactin (P69) from the yeast Pichia pastoris; high-level
production and immunological properties, Vaccine, 9 (1991)
901-906.
19 Vozza L A, Wittwer L, Higgins D R, Purcell T J, Bergseid M
et al, Production of a recombinant bovine enterokinase
catalystic subunit in the methylotropic yeast Pichia pastoris,
Biotechnology, 14 (1996) 77-81.